Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals

Pharmacogenetics

Volumn 9, Issue 4, 1999, Pages 511-516

  Xie, Hong Guang ^a   Stein, C Michael ^a   Kim, Richard B ^a   Xiao, Zhou Sheng ^b   He, Nan ^b   Zhou, Hong Hao ^b   Gainer, James V ^a   Brown, Nancy J ^a   Haines, Jonathan L ^a   Wood, Alastair J J ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allele; Beta 2 adrenergic receptor gene; Genotype; Interethnic differences; Single nucleotide polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; ASTHMA; BLOOD VESSEL REACTIVITY; CAUCASIAN; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0032844359     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Anonymous, Asthma mortality and hospitalization among children and young adults - United States, 1980-1993. MMWR -Morbid Mortal Weekly Rep 1996; 45:350-353.
2. Anonymous, The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
3. Arrighi HM. US asthma mortality: 1941 to 1989. Ann Allergy Asthma Immunol 1995; 74:321-326.
4. 2 adrenergic receptors in asthma: a current perspective. Lung 1992; 170:125-141.
5. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
6. Cardillo C, Kilcoyne CM, Cannon RO III, Panza JA. Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation 1999; 99:90-95.
7. 2-adrenoceptor polymorphism with vascular reactivity in humans (abstract). Circulation 1997; 96, 1-106.
8. Cockroft JR, Noon JP, Gazis A, White DJ, Wheatley A, Dewar J, Hall IP. β2 adrenoceptor polymorphism and vascular reactivity in human resistance and capacitance vessels (abstract). Am J Hypertens 1998; 11:14A.
9. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin invest 1990; 85:647-652.
10. Gratze G, Schoner TH, Fortin J, Labugger R, Binder A, Hohe M. Reduced β-2 mediated whole body vasodilation in subjects with the Gly16 allele of the β-2 adrenoceptor gene (abstract). J Hypertens 1998; 16 (Suppl. 2):S53.
11. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419.
12. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13:25-33.
13. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995; 345:1213-1214.
14. 2 adrenoceptor polymorphisms: are they clinically important? Thorax 1996; 51:351-353.
15. 2-adrenergic receptor (abstract). Am J Hypertens 1998; 11:165A.
16. Hongyo T, Buzard GS, Calvert RJ. Weghorst CM. 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucl Acids Res 1993; 21:3637-3642.
17. Insel PA. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors - evolving concepts and clinical implications. New Engl J Med 1996; 334:580-585.
18. 2-adrenergic agonist-induced venodilation in Indians of Asian origin. Clin Pharmacol Ther 1996; 59:569-576.
19. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987a; 84:46-50.
20. 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987b; 262:7321-7327.
21. 2-adrenoceptor. Hypertension 1997; 30:773-776.
22. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, et al. Attenuation of isoproterenol-mediated vasodilatation in blacks. New Engl J Med 1995; 333:155-160.
23. Leung RC, Carlin JB, Burdon JG, Czarny D. Asthma, allergy and atopy in Asian immigrants in Melbourne. Med J Austr 1994; 161:418-425.
24. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
25. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther 1990; 48:87-95.
26. Nelson DA, Johnson CC, Divine GW, Strauchman C, Joseph CL, Ownby DR. Ethnic differences in the prevalence of asthma in middle class children. Ann Allergy Asthma Immunol 1997; 78:21-26.
27. Poulter NR, Khaw KT, Mugambi M, Peart WS, Rose G, Sever P. Blood pressure patterns in relation to age, weight and urinary electrolytes in three Kenyan communities. Trans R Soc Trop Med Hyg 1985; 79:389-392.
28. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339.
29. Senior PA, Bhopal R. Ethnicity as a variable in epidemiological research. BMJ 1994; 309:327-330.
30. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995; 96:579-585.
31. Stein CM, Lang CC, Singh L, He HB, Wood AJJ. Increased vasoconstriction and decreased vasodilation not increased sympathetic activity are mechanisms for enhanced vascular reactivity in African-Americans (abstract). Circulation 1998; 98:1472.
32. 2 receptor polymorphism influences agonist-stimulated peripheral blood flow in normal individuals (abstract). Circulation 1998; 98:1393.
33. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997; 350:995-999.
34. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). Ann Allergy 1991; 67:147-154.
35. 2-adrenergic receptor in nocturnal and non-nocturnal asthma. Evidence that Gly 16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635-1641.
36. Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJJ. Racial differences in drug response: altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. New Engl J Med 1989; 320:565-570.